Beta blockers in the elderly: New Perspectives workshop: la napoule, september 3–4, 1988 Preface Pages: 1193 - 1193
Efficacy of celiprolol in hypertension and angina pectoris R. J. Norris Introduction Pages: 1195 - 1196
Hypertension in the elderly: Epidemiology and pathophysiology J. J. McNeilC. A. Silagy Epidemiology and Neurohumoral Mechanism Pages: 1197 - 1201
Systolic hypertension in the elderly Gale H. Rutan Epidemiology and Neurohumoral Mechanism Pages: 1203 - 1208
Neuroendocrine mechanisms and cardiovascular homeostasis in the elderly Paddy A. PhillipsG. Peter HodsmanColin I. Johnston Epidemiology and Neurohumoral Mechanism Pages: 1209 - 1213
Section I discussion: Overview of epidemiology, systolic hypertension and neurohumoral mechanisms Epidemiology and Neurohumoral Mechanism Pages: 1215 - 1216
Cerebral blood flow in the elderly: Impact of hypertension and antihypertensive treatment Svend Strandgaard Cerebral Blood Flow, Cardiovascular Reflexes, and Respiratory Function Pages: 1217 - 1221
Reflex control of circulation in the elderly G. ManciaJ. ClérouxG. Grassi Cerebral Blood Flow, Cardiovascular Reflexes, and Respiratory Function Pages: 1223 - 1228
Respiratory function in the elderly and the effects of beta blockade A. E. Tattersfield Cerebral Blood Flow, Cardiovascular Reflexes, and Respiratory Function Pages: 1229 - 1232
Section 2 discussion: Cerebral blood flow, cardiovascular reflexes, and respiratory function Cerebral Blood Flow, Cardiovascular Reflexes, and Respiratory Function Pages: 1233 - 1235
Review of the major hypertension trials in the elderly Jan StaessenRobert FagardAntoon Amery Overview of Major Trials and Key Factors in Treatment Pages: 1237 - 1247
Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: Focus on systolic hypertension Kevin O'MalleyJohn P. CoxEoin O'Brien Overview of Major Trials and Key Factors in Treatment Pages: 1249 - 1251
Key learnings from the STOP-Hypertension study: An update on the progress of the ongoing Swedish study of antihypertensive treatment in the elderly Lennart HanssonBjörn DahlöfPer-Olov Wester Overview of Major Trials and Key Factors in Treatment Pages: 1253 - 1255
Age-related changes in autonomic control: The use of beta blockers in the treatment of hypertension Kenneth John Collins Overview of Major Trials and Key Factors in Treatment Pages: 1257 - 1262
Key factors in the treatment of the elderly hypertensive John L. C. Dall Overview of Major Trials and Key Factors in Treatment Pages: 1263 - 1268
Section 3 discussion: Overview of major trials and key factors in treatment Overview of Major Trials and Key Factors in Treatment Pages: 1269 - 1271
Required beta blocker profile in the elderly L. H. Opie Required Beta-Blocker Profile Pages: 1273 - 1280
Pharmacology of celiprolol W. J. LouisO. H. DrummerL.-H. Tung Required Beta-Blocker Profile Pages: 1281 - 1285
The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels Roberto FogariAnnalisa ZoppiCarlo Pasotti Required Beta-Blocker Profile Pages: 1287 - 1290
Evaluation of celiprolol, a new cardioselective beta1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly K. D. Lamon Required Beta-Blocker Profile Pages: 1291 - 1295
Section 4 discussion: Required beta-blocker profile: Data on celiprolol Required Beta-Blocker Profile Pages: 1297 - 1299
A round table discussion: Blood pressure techniques. systolic hypertension. aims of therapy. choice of treatment Round Table Discussion on Antihypertensive Therapy in the Elderly Pages: 1301 - 1304
Hypertension in the elderly. Beta-blockade and celiprolol Round Table Discussion on Antihypertensive Therapy in the Elderly Pages: 1305 - 1305
